High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).
暂无分享，去创建一个
G. Montalescot | J. Hulot | J. Collet | J. Silvain | F. Beygui | G. Cayla | J. Vignalou | C. Caron | V. Gallois | Ghalia Anzaha | S. Galier | A. Pena | T. Chastre | A. Bellemain‐Appaix | O. Barthelemy | Sophie Galier | Vanessa Gallois